Axon Enterprise (AXON) opened 2026 with Q1 revenue of $807.3 million and basic EPS of $2.11, as the company put up another quarter of solid top line and earnings delivery. Over the past year, revenue has stepped up from $575.1 million in Q4 2024 to $603.6 million in Q1 2025 and then to $807.3 million in Q1 2026, while quarterly basic EPS moved from $1.77 to $1.14 and then to $2.11. This gives investors plenty to weigh regarding the consistency and quality of margins behind these results.

See our full analysis for Axon Enterprise.

With the headline numbers on the table, the next step is to set these earnings against the most common stories around Axon to see which narratives hold up and which start to look out of date.

TTM margin at 6.9% after one off gain

• Over the last 12 months, Axon generated US$2.98b of revenue and US$206.0 million of net income, which works out to a 6.9% net margin compared with 14.9% in the prior year period.
• What stands out for the bullish narrative is that this 6.9% margin includes a US$107.1 million one off gain, yet bulls still expect earnings of US$641.9 million by around 2028, so:
  • Five year earnings growth of 40.7% a year and the move to profitability support the idea of a stronger business, but the lower recent margin and one off item mean reported profitability is flattered by non recurring factors.
  • This gap between cleaner underlying margins and bullish earnings targets is exactly where investors need to check whether expected growth in higher margin software and services can offset any pressure in hardware or compliance costs.

Bulls argue Axon’s AI and SaaS mix could support long term earnings power that current margins do not fully reflect, and you can see how that case lines up with these numbers in the 🐂 Axon Enterprise Bull Case.

Premium P/S multiple versus peers

• Axon trades on a P/S of 11.5x, compared with 7.9x for peers and 5.5x for the broader US Aerospace & Defense industry, while the current share price of US$426.89 sits above the DCF fair value estimate of about US$377.80.
• Skeptics focus on this valuation gap, arguing that even with forecast revenue growth of 20.2% a year and earnings growth of 31.9% a year, investors are already paying a premium, so:
  • The combination of a higher multiple, a 6.9% trailing margin and a one off gain gives bears room to question how much of the expected growth is already reflected in the current price.
  • The fact that the share price is above the DCF fair value encourages careful review of whether long term cash flow assumptions, rather than just top line growth, support paying more than the modelled value.

Skeptics point to Axon’s rich P/S and gap to DCF fair value as reasons to stress test the cautious case more closely in the 🐻 Axon Enterprise Bear Case.

Earnings volatility around a growing revenue base

• Over the last five reported quarters, revenue moved from US$603.6 million in Q1 2025 to US$807.3 million in Q1 2026, while basic EPS swung from US$1.14 to US$0.46, then small losses and low profits, before landing at US$2.11 in the latest period.
• The consensus narrative leans on recurring software and international expansion as supports for long term growth, and these swings in EPS alongside growing revenue highlight the tension between:
  • Quarterly earnings that can be choppy, including periods where net income was close to breakeven or slightly loss making, even as trailing twelve month revenue stepped up from US$2.08b to US$2.98b.
  • Analyst forecasts that look for revenue to grow about 29.6% a year and earnings to reach US$571.8 million by around 2029, which assume that this revenue base increasingly converts into steadier and larger profits over time.

Next Steps

To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for Axon Enterprise on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.

If this mix of risks and rewards still feels finely balanced, now is the moment to look through the numbers yourself and decide where you stand. Then weigh that view against the 1 key reward and 3 important warning signs in the 1 key reward and 3 important warning signs.

See What Else Is Out There

Axon’s premium P/S multiple, modest 6.9% trailing margin and reliance on one off gains leave plenty of questions around how much investors are already paying for.

If that rich pricing makes you uneasy, you can compare this setup with companies that pair stronger value with quality by checking out the 51 high quality undervalued stocks.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.